Stereotaxis and ADAS 3D Combine Robotic Precision and Advanced Preoperative Substrate Mapping to Treat Cardiac Arrhythmias

Stock Information for Stereotaxis Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Stereotaxis Inc.

Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
Stereotaxis Reports 2023 Full Year Financial Results
Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology
Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.